medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2016, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2016; 15 (4)


Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant

Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N

Idioma: Ingles.
Referencias bibliográficas: 20
Paginas: 545-549
Archivo PDF: 137.69 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132: 2557-76. Doi: 10.1053/j.gastro.2007.04.061.

  2. Sarkar M, Watt KD, Terrault N, Berenguer M. Outcomes in liver transplantation: does sex matter? J Hepatol 2015; 62: 946-55. Doi: 10.1016/j.jhep.2014.11.023.

  3. Bruix J, Sherman M. Management of Hepatocellular Carcinoma: An Update. Hepatology 2010; 53: 1-35.

  4. Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, Zhao GJ, et al. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin/T cell factor- dependent hepatocarcinogenesis. J Clin Invest 2011; 121: 3159-75. Doi: 10.1172/JCI45967.

  5. Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY. Alpha- fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl 2014; 20: 945-51. Doi: 10.1002/lt.23904.

  6. Hakeem AR, Young RS, Marangoni G, Lodge JP, Prasad KR. Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther 2012; 35: 987-99. Doi: 10.1111/ j.1365-2036.2012.05060.x.

  7. Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnu L, Rapaccini G, et al. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? Eur J Gastroenterol Hepatol 2009; 21: 1212-8. Doi: 10.1097/ MEG.0b013e32831a86f8.

  8. Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, Francoz C, et al. Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology 2012; 143: 986-94 e3; quiz e14-5. Doi: 10.1053/ j.gastro.2012.05.052.

  9. Samoylova ML, Dodge JL, Yao FY, Roberts JP. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl 2014; 20: 937-44. Doi: 10.1002/lt.23902.

  10. Samoylova ML, Dodge JL, Vittinghoff E, Yao FY, Roberts JP. Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database. Liver Transpl 2013; 19: 1318-23. Doi: 10.1002/ lt.23735.

  11. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-90. Doi: 10.1111/ j.1600-6143.2006.01242.x.

  12. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496- 509.

  13. National Institutes of Health. Available at: URL. 2015.

  14. Cieloszyk K, Hartel D, Moskaleva G, Schoenbaum EE. Effects of hepatitis C virus infection on menopause status and symptoms. Menopause 2009; 16: 401-6. Doi: 10.1097/ gme.0b013e318186d7cf.

  15. Valimaki M, Pelkonen R, Salaspuro M, Harkonen M, Hirvonen E, Ylikahri R. Sex hormones in amenorrheic women with alcoholic liver disease. J Clin Endocrinol Metab 1984; 59: 133-8. Doi: 10.1210/jcem-59-1-133.

  16. Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, Shima T, et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011; 9: 428-33; quiz e50. Doi: 10.1016/j.cgh.2011.01.023.

  17. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA 2015; 313: 2263-73. Doi: 10.1001/ jama.2015.5370.

  18. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625- 38. Doi: 10.1056/NEJMoa021423.

  19. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-8.

  20. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010; 51: 1820-32. Doi: 10.1002/hep.23594.




2020     |     www.medigraphic.com